Manulife (Manufacturers Life Insurance)
CBIO

Manulife (Manufacturers Life Insurance)’s Crescent Biopharma CBIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$457K Hold
24,903
– – ﹤0.01% 2199
2025
Q4 		$289K Sell
24,903
-20
-0.1% -$255 ﹤0.01% 2373
2025
Q3 		$296K Buy
+24,923
New +$331K ﹤0.01% 2396
2021
Q1 		– Sell
-259
Closed -$97K – 3092
2020
Q4 		$97K Buy
259
+35
+16% +$12.3K ﹤0.01% 2957
2020
Q3 		$69K Buy
+224
New +$85.6K ﹤0.01% 2866
2020
Q2 		– Sell
-246
Closed -$56K – 2879
2020
Q1 		$56K Buy
246
+27
+12% +$10.3K ﹤0.01% 2718
2019
Q4 		$116K Sell
219
-6
-3% -$3.25K ﹤0.01% 2763
2019
Q3 		$99K Hold
225
– – ﹤0.01% 2822
2019
Q2 		$268K Sell
225
-10
-4% -$12K ﹤0.01% 2437
2019
Q1 		$293K Buy
235
+17
+8% +$19.5K ﹤0.01% 2279
2018
Q4 		$206K Sell
218
-14
-6% -$16.8K ﹤0.01% 2301
2018
Q3 		$333K Sell
232
-26
-10% -$39.3K ﹤0.01% 2495
2018
Q2 		$416K Buy
258
+248
+2,480% +$426K ﹤0.01% 2537
2018
Q1 		$17K Buy
10
+1
+11% +$2.08K ﹤0.01% 3788
2017
Q4 		$15K Buy
9
+1
+13% +$1.32K ﹤0.01% 3873
2017
Q3 		$11K Buy
+8
New +$9.39K ﹤0.01% 3797
2017
Q2 		– Sell
-2
Closed -$1K – 4393
2017
Q1 		$1K Hold
2
– – ﹤0.01% 4044
2016
Q4 		$1K Buy
+2
New +$1.25K ﹤0.01% 4191

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s CBIO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) held its Crescent Biopharma (CBIO) position steady in Q1 2026 at 24,903 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Manulife (Manufacturers Life Insurance) first reported a position in CBIO in Q4 2016 and has held it in 18 quarters since. 63 funds tracked by Wall St. Rank hold CBIO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 24,903 shares of Crescent Biopharma worth $457K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) left its Crescent Biopharma share count unchanged in Q1 2026.
  • Crescent Biopharma made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2199 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Crescent Biopharma in Q4 2016 and has held it in 18 quarters since.
  • 63 funds tracked by Wall St. Rank held Crescent Biopharma as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.